Sight Sciences
Price & Volume
Stats
See moreOpen | $3.32 |
Previous Close | $3.31 |
Day Range | $3.31-$3.38 |
52W Range | $2.03-$6.29 |
Market Cap | $177.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $76.3M |
Revenue Growth (YoY) | -8.5% |
Gross Profit (12 Mos) | $65.1M |
Diluted EPS | -$0.95 |
News
See moreYahoo Finance • 16 days ago
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
Yahoo Finance • 24 days ago
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
Yahoo Finance • last month
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
Yahoo Finance • last month
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
About
CEO | Mr. Paul Badawi |
CFO | Ms. Alison Perry Bauerlein |
Address | 4040 Campbell Avenue, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 216 |
